Device Trial Radar · NCT01106417
Safety and Efficacy Study of NeoFuse in Subjects Undergoing Multi-Level Anterior Cervical Discectomy and Fusion
Last checked: Nov 19, 2026Latest source record: Jun 29, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
12
Actual
Start
Jun 2010
Primary completion
May 2012
Study completion Mar 2013
Sponsor
- Lead sponsor
- Mesoblast, Ltd.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Apr 19, 2010
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety and preliminary efficacy of NeoFuse in subjects with a diagnosis of degenerative disc disease (DDD) at 2 or more adjacent cervical vertebral levels between C3-C4 to C7-T1. All subjects in this study will undergo 2 or 3 level anterior cervical discectomy and fusion with Anterior Cervical Plate Fixation.
Conditions
- Cervical Degenerative Disc Disease
- Degenerative Spondylolisthesis
- Spinal Stenosis
Interventions
NeoFuseBiological
Single Dose NeoFuse Surgical Implantation
MasterGraft GranulesDevice
Single Dose MaterGraft Granules Surgical Implantation
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety of NeoFuseTime frame: 2 years
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Monash Medical Centre
Clayton, Victoria, Australia
Royal Melbourne Hospital
Melbourne, Victoria, Australia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.